CHARLOTTE, NC, April 06, 2022 (GLOBE NEWSWIRE) — DENTSPLY SIRONA Inc. (“Dentsply Sirona”) (Nasdaq: XRAY) today announced that Mr. John P. Groetelaars has been appointed to its Board of administration (the “Board”), increasing the size of its Board from eleven to twelve members.
“We are delighted to welcome John Groetelaars to the Dentsply Sirona Board of Directors,” said Eric K. Brandt, Non-Executive Chairman of the Board. “John brings over 30 years of MedTech experience with 20 years of international experience, including as former CEO of Hillrom. John’s deep experience in medical technology and leadership roles will be a valuable addition to our Board of Directors. We look forward to working with him as we continue to advance patient care through innovative, high quality dental solutions.”
Mr. John P. Groetelaars served as President, Chief Executive Officer and a member of Hillrom’s Board of Directors from May 2018 until the company’s acquisition by Baxter International, Inc., in December 2021. At Hillrom, he had corporate responsibility for a global health technology company with $3 billion in revenue and over 10,000 employees. Mr. Groetelaars led a transformation of Hillrom’s business, successfully articulating and launching a new connected care strategy and vision, growing the portfolio through seven acquisitions and one divestiture, and delivering record financial performance. In addition, he actively championed and led diversity, inclusion, equity and belonging initiatives across the company, which led to record levels of employee engagement and external recognition of DiversityInc, Forbes and many other organizations. Prior to Hillrom, Mr. Groetelaars served as Executive Vice President and President of the Interventional Segment at Becton, Dickinson and Company, a medical technology company, since December 2017 following its acquisition of CR Bard Inc., a medical technology company, where his responsibilities include global strategic, financial, operational and innovation platforms. Previously, he held various progressive positions at CR Bard during his 10-year career, including as Group President from 2015 to 2017. Mr. Groetelaars joined CR Bard in 2008 as Vice President and General Manager , Davol Inc., and was named Chairman of Davol in 2009. In 2013, Mr. Groetelaars was promoted to Group Vice President and in 2015 he was promoted to Group President, a position he held until the acquisition of CR Bard by Becton, Dickinson and Company in December 2017. prior to joining CR Bard, Mr. Groetelaars held various international management positions in Canada, Denmark and the United Kingdom with Boston Scientific Corporation from 2001 to 2008 Prior to joining Boston Scientific, Mr. Groetelaars held general management, marketing, business development and sales positions with Guidant Corporation and Eli Lilly. He was also previously a director on the board of AdvaMed.
About Dentsply Sirona
Dentsply Sirona is the world’s largest manufacturer of professional dental products and technologies, with a 135-year history of innovation and service to the dental industry and patients worldwide. Dentsply Sirona develops, manufactures and markets a comprehensive solutions offering including dental and oral health products and other consumable medical devices under a strong portfolio of world-class brands. As The Dental Solutions Company, Dentsply Sirona products provide innovative, high quality and effective solutions to advance patient care and deliver better, safer and faster dentistry. The Company’s common stock is listed in the United States on the Nasdaq under the symbol XRAY. Visit www.dentsplysirona.com for more information about Dentsply Sirona and its products.
Contact information
Investors:
Andrea Daley
Vice President, Investor Relations
+1-704-805-1293
InvestorRelations@dentsplysirona.com
